How I treat MDS and AML in Fanconi anemia
Fanconi anemia (FA) is the most frequent genetic cause of bone marrow failure (BMF).1 More than 18 FA
How I vaccinate blood and marrow transplant recipients
15:05
סגור לתגובות על How I vaccinate blood and marrow transplant recipients
Paul A. Carpenter and Janet A. Englund
Blood 2016 127:2824-2832
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
17:18
סגור לתגובות על The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J. Borowitz, Michelle M. Le Beau, Clara D. Bloomfield, Mario Cazzola and James W. Vardiman
Blood 2016 127:2391-2405
Stem Cell Transplantation for Children with Malignant Diseases – למתמחים
11:13
סגור לתגובות על Stem Cell Transplantation for Children with Malignant Diseases – למתמחים
מצגת מאת Jerry Stein
How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver
15:13
סגור לתגובות על How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver
George B. McDonald
Blood 2016 127:1544-1550
How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation
14:30
סגור לתגובות על How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation
Alpana Waghmare, Janet A. Englund, Michael Boeckh
Blood Jun 2016, 127 (22) 2682-2692; DOI: 10.1182/blood-2016-01-634873
Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients
16:38
סגור לתגובות על Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients
Vijay Ramaswamy, Marc Remke, Jennifer Adamski, Ute Bartels, Uri Tabori, Xin Wang, Annie Huang, Cynthia Hawkins, Donald Mabbott,
Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group
16:18
סגור לתגובות על Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group
Journal of Clinical Oncology, 34:117-122.
Metastatic Rhabdomyosarcoma: Still Room for Improvement
16:13
סגור לתגובות על Metastatic Rhabdomyosarcoma: Still Room for Improvement
Journal of Clinical Oncology, Vol 34, No 2 (January 10), 2016: pp 105-106
Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis
14:49
סגור לתגובות על Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis
Shahrukh Hashmi,Mohammad Ahmed,M Hassan Murad,Mark R Litzow,Roberta H Adams,Lynne M Ball,Vinod K Prasad,Partow Kebriaei,Olle Ringden
The Lancet Haematology,
